Advertisement
Psychemedics Corporation

Psychemedics Corporation (PMD) Stock Overview

Explore Psychemedics Corporation’s financial performance, market position, analyst ratings, and future outlook.

PMDNASDAQ
HealthcareMedical - Diagnostics & Research
$2.67
$0.00(0.00%)
U.S. Market is Open · 12:13
Advertisement

Psychemedics Corporation (PMD)

Meyka AI Score

Z

Key Financials

Market Cap15.6M
P/E Ratio-8.42
EPS (TTM)$-0.51
ROE-0.32%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

PMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Psychemedics Corporation (PMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.42 and a market capitalization of 15.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
20.81%
3-Year Change
-56.94%
5-Year Change
-62.66%
All-Time (Max) Change
-78.84%

Contact Information

978 206 8220
289 Great Road, Acton, MA, 01720

Company Facts

1,160 Employees
IPO DateJan 22, 1987
CountryUS

Frequently Asked Questions